Synergies From Integrating Randomized Controlled Trials and Real-World Data Analyses.

Area of Science:

• Real-world evidence
• Clinical trial methodology
• Health services research

Background:

• Administrative claims databases and national registries offer real-world medication data for large, diverse populations.
• Claims-based nonrandomized studies and randomized-controlled trials (RCTs) have inherent limitations but complementary strengths.
• Existing research often analyzes these data sources separately.

Purpose of the Study:

• To propose a method for integrating longitudinal claims data from RCT participants.
• To highlight the added value of combining RCT and claims data through "information overlap."
• To enhance the understanding of medication benefits and harms in real-world settings.

Main Methods:

• Utilizing administrative claims data collected routinely from participants in randomized-controlled trials.
• Leveraging the longitudinal nature of claims data for in-depth analysis.
• Analyzing the combined dataset to identify synergistic evidence.

Main Results:

• The integration of RCT and claims data offers substantial synergies.
• Novel evidence can be derived from the "information overlap" between these data sources.
• This approach can provide more comprehensive estimates of medication benefits and harms.

Conclusions:

• Combining RCT and claims data provides complementary strengths for robust real-world evidence.
• The proposed method enhances the value of existing clinical trial data.
• This integrated approach improves the assessment of medication effectiveness and safety.